Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
•
General Rheumatology
•
DMARD
How do you handle medication refills for patients on traditional DMARDs who are lost to follow-up?
Related Questions
Do you continue PJP prophylaxis indefinitely in patients on rituximab maintenance therapy?
How do you approach vaccination, particularly the use of live vaccines such as yellow fever, in a patient with rheumatoid arthritis receiving a TNF inhibitor who is planning travel to Africa?
In a patient with a history of seropositive erosive RA who has undergone treatment for a periprosthetic joint infection and currently has an antibiotic spacer in place with clinical improvement, what is the appropriate timing and strategy for restarting DMARDs and/or biologic therapy to balance infection risk with RA disease control?
What is your typical steroid taper regimen for managing RA flares?
How do you taper corticotropin injections (Acthar) in patients with rheumatologic disease?
Do you always get a baseline chest xray in patients who will be starting methotrexate?
What is your approach to methotrexate use (or avoidance) in patients with varying MTHFR mutations?
How do you approach diagnosis in a patient with inflammatory joint symptoms and isolated bilateral CMC joint erosions on x-ray imaging?
How do you approach management of a patient with multiple lung nodules and low titer +CCP but no active joint symptoms suggestive of RA?
Are there specific combinations of DMARDs and/or biologics that you avoid due to elevated infection risk or other safety concerns?
